Search

The Impact of Topical Treatment on the Eye Joseph Sowka, O.D. Along with sight-saving agents, glaucoma patients on chronic, long-term therapy are also exposed to a lot of preservatives in [...]

The examination of the optic nerve head is fundamental to all of aspects of glaucoma diagnosis and evaluation, yet it is the exam component most often neglected by clinicians. A [...]

Glaucoma is a progressive optic neuropathy that damages retinal ganglion cells and other mechanisms in the visual pathway. The result is a loss of sensitivity, first in the peripheral vision [...]

History A 67-year-old Black female reported to the office for a glaucoma follow-up. She explained that her eye pressure had been managed by another doctor, but--since that practice no longer [...]

A 64-year-old white female, "Lucy," presented to our office as a referral from a local optometrist. The referring optometrist was concerned about a spike in intraocular pressure (IOP) secondary to [...]

I've had the good fortune to work in an inner-city immigrant clinic for the past 10 years. Most of our patients are referred by their primary care physicians for an [...]

Surgical intervention becomes an option in the management of open-angle glaucoma when the intraocular pressure (IOP) cannot be sufficiently reduced with medical or laser therapy to prevent progressive optic nerve [...]

The last decade has seen an explosion of new technologies that have begun to challenge our understanding of the structural and functional relationships in early glaucoma, while at the same [...]

As students, many of us were taught to base a diagnosis of glaucoma on a triad of findings: elevated intraocular pressure (IOP), optic nerve damage and visual field loss. If [...]

If the sky was the limit on your budget, your space and your ability, what diagnostic equipment would you want in your practice? How would it help your patients? How [...]

Many times, patients who are on ocular hypotensive medications prescribed by other doctors will transfer to your practice. Taking on these new glaucoma or ocular hypertension (OHTN) patients can be [...]

The entire field of glaucoma has been on a plateau now for several years--and it is a nicely adequate plateau. The diagnostic and therapeutic armamentarium is amply sufficient for superb [...]

Case 1: Ideal Scenario for a Fixed Combination A 58-year-old African-American male presented for a routine exam. He was in excellent systemic health but had IOP of 33mm Hg in [...]

Patients who present with either corneal disorders or glaucoma requiring surgical intervention are commonly seen in clinical optometric practice. As with cataract surgery, primary-care optometric physicians can develop and refine [...]

The year 2007 may not be remembered as a year for groundbreaking developments in glaucoma. Several smaller advances, however, have contributed toward moving the field forward. In particular, there continues [...]

Release Date: October 2007 Expiration Date: October 31, 2008 Goal Statement: The field of glaucoma is rich with research and is ever-changing--both on the therapeutic side and on the technology [...]

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2007.06.023 Byline: Paul P. Lee (a), John G. Walt (b), Tina H. Chiang (b), Angela Guckian (c), John Keener (d) Abstract: To develop an alternative method for analysis of patient persistence with prescribed medications using the prostaglandin class of intraocular pressure (IOP)-lowering drugs as a model. Author Affiliation: (a) Duke Eye Center, Duke University, Durham, North Carolina (b) Allergan, Inc, Irvine, California (c) Wolters Kluwer Health, Phoenix, Arizona (d) BioComm LLC, Laguna Beach, California. Article History: Accepted 13 June 2007

The last decade has seen an explosion of new technologies that have begun to challenge our understanding of the structural and functional relationships in early glaucoma, while at the same [...]

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2007.01.046 Byline: Esther M. Hoffmann (a)(b), Catherine Boden (a), Linda M. Zangwill (a), Christopher Bowd (a), Felipe A. Medeiros (a), Jonathan G. Crowston (a)(c), Pamela A. Sample (a), Robert N. Weinreb (a) Abstract: To determine the spatial relationship in neuroretinal rim parameter values between eyes in ocular hypertensives, glaucoma suspects, and glaucoma patients. Author Affiliation: (a) Hamilton Glaucoma Center, Department of Ophthalmology, UC San Diego, La Jolla, California (b) Department of Ophthalmology, University of Mainz, Germany (c) University of Melbourne, Australia. Article History: Accepted 25 January 2007

If you ask a fellow optometrist for his or her preferred treatment for glaucoma, the usual response will be drops first, then surgery if necessary. However, as surgical techniques continue [...]

The last decade has seen an explosion of new technologies that have begun to challenge our understanding of the structural and functional relationships in early glaucoma, while at the same [...]

Definitions Bruce Onofrey, OD, RPh, FAAO: The purpose of this discussion is to tie together two seemingly disparate chronic problems that we face in managing our patients: glaucoma and ocular [...]

Prior to the 1990s, few geneticists were interested in identifying glaucoma genes. After all, the disease had a late age of onset, and they estimated that the heritability of glaucoma [...]

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2006.04.027 Byline: Diana Ng, Linda M. Zangwill, Lyne Racette, Christopher Bowd, John P. Pascual, Rupert R.A. Bourne, Catherine Boden, Robert N. Weinreb, Pamela A. Sample Abstract: To assess agreement between structural and functional testing in classifying eyes as normal or abnormal and their repeatability on two consecutive visits by means of standard automated perimetry (SAP) and confocal scanning laser ophthalmoscopy. Author Affiliation: Hamilton Glaucoma Center Department of Ophthalmology, University of California at San Diego, La Jolla, California. Article History: Accepted 16 April 2006 Article Note: (footnote) Supported in part by National Eye Institute grants EY11008 (L.M.Z.) and EY08208 (P.A.S.). Alcon Laboratories Inc, Allergan, Pfizer Inc, and SANTEN Inc. Research funding or materials from Carl Zeiss Meditec (P.A.S., L.M.Z., R.N.W.), Heidelberg Engineering (P.A.S., L.M.Z., R.N.W., R.R.A.B.), Welch-Allyn (P.A.S.), and Haag-Streit (P.A.S.); honoraria from Heidelberg Engineering (L.M.Z., R.N.W.) and Carl Zeiss Meditec (R.N.W.).

A healthy 53-year-old black male presents for a routine exam. His intraocular pressure measures 23mm Hg O.U and his cup-to-disc ratios measure 0.70 x 0.70 O.U. His rim tissue is [...]

Signs and Symptoms While any person can experience acute angle closure glaucoma (AACG), this condition is most common in patients of Asian descent. (1-6) Patients are also likely to be [...]

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2005.11.001 Byline: Suad AlFadhli (a), Abdulmutalib Behbehani (b), Alaa Elshafey (c), Sidky Abdelmoaty (d), Sadiqa Al-Awadi (c) Abstract: To report the spectrum of the CYP1B1 mutation in Kuwaiti patients with primary congenital glaucoma (PCG). Author Affiliation: (a) Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Kuwait (b) Department of Surgery, Faculty of Medicine, Kuwait University, Kuwait (c) Kuwait Medical Genetic Center, Kuwait (d) Al Bahar Eye Center, Kuwait Article History: Accepted 1 November 2005 Article Note: (footnote) The project was supported by Faculty of Allied Health Sciences at Kuwait University.